Mark Schoenberg

CIK: 0001763581

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)18 (56.3%)

Position reduction

Option Exercises (M)12 (37.5%)

Derivative conversions

Awards (A)2 (6.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

URGN

UroGen Pharma Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (32 total)

URGN
UroGen Pharma Ltd.
Sep 8, 2026
Sale(S)
Direct
871 shares at avg. $42.92$37K
URGN
UroGen Pharma Ltd.
Sep 7, 2026
Exercise(M)
Direct
1.7K shares-
URGN
UroGen Pharma Ltd.
Aug 20, 2026
Sale(S)
Direct
60.7K shares at avg. $47.05$2.9M
URGN
UroGen Pharma Ltd.
Jul 9, 2026
Sale(S)
Direct
10K shares at avg. $40.00$400K
URGN
UroGen Pharma Ltd.
Jun 22, 2026
Sale(S)
Direct
10K shares at avg. $35.01$350K
URGN
UroGen Pharma Ltd.
Jun 8, 2026
Exercise(M)
Direct
10K shares-
URGN
UroGen Pharma Ltd.
Jun 8, 2026
Sale(S)
Direct
5.2K shares at avg. $27.30$143K
URGN
UroGen Pharma Ltd.
May 8, 2026
Sale(S)
Direct
10K shares at avg. $30.00$300K
URGN
UroGen Pharma Ltd.
Feb 3, 2026
Sale(S)
Direct
1.8K shares at avg. $19.69$36K
URGN
UroGen Pharma Ltd.
Feb 3, 2026
Sale(S)
Direct
1.8K shares at avg. $19.69$36K
URGN
UroGen Pharma Ltd.
Feb 3, 2026
Sale(S)
Direct
3.7K shares at avg. $19.69$73K
URGN
UroGen Pharma Ltd.
Jan 31, 2026
Exercise(M)
Direct
3.3K shares-
URGN
UroGen Pharma Ltd.
Jan 31, 2026
Exercise(M)
Direct
6.7K shares-
URGN
UroGen Pharma Ltd.
Jan 31, 2026
Exercise(M)
Direct
3.3K shares-
URGN
UroGen Pharma Ltd.
Jan 31, 2026
Award(A)
Restricted Stock Units
Direct
20K shares-
URGN
UroGen Pharma Ltd.
Nov 19, 2025
Sale(S)
Direct
10K shares at avg. $25.00$250K
URGN
UroGen Pharma Ltd.
Sep 8, 2025
Sale(S)
Direct
871 shares at avg. $19.11$17K
URGN
UroGen Pharma Ltd.
Sep 7, 2025
Exercise(M)
Direct
1.7K shares-
URGN
UroGen Pharma Ltd.
Aug 11, 2025
Sale(S)
Direct
10K shares at avg. $17.69$177K
URGN
UroGen Pharma Ltd.
Jul 28, 2025
Exercise(M)
Direct
10K shares-
URGN
UroGen Pharma Ltd.
Jul 28, 2025
Sale(S)
Direct
5.1K shares at avg. $19.14$99K
URGN
UroGen Pharma Ltd.
Jun 9, 2025
Sale(S)
Direct
5.2K shares at avg. $7.37$38K
URGN
UroGen Pharma Ltd.
Jun 8, 2025
Exercise(M)
Direct
10K shares-
URGN
UroGen Pharma Ltd.
Jan 31, 2025
Award(A)
Restricted Stock Units
Direct
20K shares-
URGN
UroGen Pharma Ltd.
Jan 31, 2025
Exercise(M)
Direct
1.3K shares-

		Type	Shares	Price		Ownership
Sep 8, 2026	URGN UroGen Pharma Ltd.	Sale(S)	871	$42.92	$37,383	Direct
Sep 7, 2026	URGN UroGen Pharma Ltd.	Exercise(M)	1,667	-	$0	Direct
Aug 20, 2026	URGN UroGen Pharma Ltd.	Sale(S)	60,677	$47.05	$2,854,853	Direct
Jul 9, 2026	URGN UroGen Pharma Ltd.	Sale(S)	10,000	$40.00	$400,000	Direct
Jun 22, 2026	URGN UroGen Pharma Ltd.	Sale(S)	10,000	$35.01	$350,100	Direct
Jun 8, 2026	URGN UroGen Pharma Ltd.	Exercise(M)	10,000	-	$0	Direct
Jun 8, 2026	URGN UroGen Pharma Ltd.	Sale(S)	5,222	$27.30	$142,561	Direct
May 8, 2026	URGN UroGen Pharma Ltd.	Sale(S)	10,000	$30.00	$300,000	Direct
Feb 3, 2026	URGN UroGen Pharma Ltd.	Sale(S)	1,844	$19.69	$36,308	Direct
Feb 3, 2026	URGN UroGen Pharma Ltd.	Sale(S)	1,843	$19.69	$36,289	Direct
Feb 3, 2026	URGN UroGen Pharma Ltd.	Sale(S)	3,686	$19.69	$72,577	Direct
Jan 31, 2026	URGN UroGen Pharma Ltd.	Exercise(M)	3,333	-	$0	Direct
Jan 31, 2026	URGN UroGen Pharma Ltd.	Exercise(M)	6,666	-	$0	Direct
Jan 31, 2026	URGN UroGen Pharma Ltd.	Exercise(M)	3,334	-	$0	Direct
Jan 31, 2026	URGN UroGen Pharma Ltd.	Award(A) Restricted Stock Units	20,000	-	-	Direct
Nov 19, 2025	URGN UroGen Pharma Ltd.	Sale(S)	10,000	$25.00	$250,000	Direct
Sep 8, 2025	URGN UroGen Pharma Ltd.	Sale(S)	871	$19.11	$16,645	Direct
Sep 7, 2025	URGN UroGen Pharma Ltd.	Exercise(M)	1,667	-	-	Direct
Aug 11, 2025	URGN UroGen Pharma Ltd.	Sale(S)	10,000	$17.69	$176,900	Direct
Jul 28, 2025	URGN UroGen Pharma Ltd.	Exercise(M)	10,000	-	-	Direct
Jul 28, 2025	URGN UroGen Pharma Ltd.	Sale(S)	5,149	$19.14	$98,552	Direct
Jun 9, 2025	URGN UroGen Pharma Ltd.	Sale(S)	5,162	$7.37	$38,044	Direct
Jun 8, 2025	URGN UroGen Pharma Ltd.	Exercise(M)	10,000	-	-	Direct
Jan 31, 2025	URGN UroGen Pharma Ltd.	Award(A) Restricted Stock Units	20,000	-	-	Direct
Jan 31, 2025	URGN UroGen Pharma Ltd.	Exercise(M)	1,334	-	-	Direct

1-25 of 32 transactions

About Schoenberg Mark

Schoenberg Mark (SEC CIK 0001763581) files insider reports with the SEC as Chief Medical Officer of UroGen Pharma Ltd. (URGN).

Signal8 holds 15 ownership filings by Schoenberg Mark, all Form 4s, filed between Sep 12, 2024 and Sep 9, 2026. Those filings report 32 transactions, from Sep 9, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schoenberg Mark's filings is in PRINCETON, NJ.

Recent filings by Schoenberg Mark

Sep 8, 2026: Open-market sale of URGN shares (Form 4, code S).
Sep 7, 2026: Option exercise of URGN shares (Form 4, code M).
Aug 20, 2026: Open-market sale of URGN shares (Form 4, code S).
Jul 9, 2026: Open-market sale of URGN shares (Form 4, code S).
Jun 22, 2026: Open-market sale of URGN shares (Form 4, code S).

Other insiders filing for UroGen Pharma Ltd. (URGN)

Degnan Chris, Chief Financial Officer
Smith Jason Drew, General Counsel
Robinson James A. Jr., Director
Wildman Daniel George, Director
Holden Stuart, Director
BUTITTA CYNTHIA M, Director

How to read Form 4 transaction codes